Industry News

44th World Hospital Congress Kicks Off with Healthcare Leaders Coming Together for Four-Day Event

By HospiMedica International staff writers
09 Nov 2021

Image: First day at 44th World Hospital Congress (Photo courtesy of The International Hospital Federation)

The 44th World Hospital Congress (WHC) organized by the International Hospital Federation (IHF; Geneva, Switzerland) kicked off in Barcelona, Spain, a year later than originally planned due to the COVID-19 pandemic.


The WHC is a unique global forum connecting leaders and decision-makers of hospitals, health services, and healthcare organizations to share knowledge and good practices, exchange new ideas and innovations, and network with other senior executives from across the international healthcare community. The WHC is the premier event in the IHF calendar and their organizing partner and host for the 44th WHC is La Unió Catalana d’Hospitals (UCH). For the first time, the WHC is fully hybrid, facilitating the participation of more than 1,200 delegates from over 70 countries in the entire program whether they attend in-person and virtually over a period of four days from 8-11 November.


The theme for this 44th WHC is “People on board: Transforming healthcare by blending agility, responsiveness, and resilience”. For four days, leaders and decision-makers in the healthcare community will share knowledge and good practices, exchange new ideas and innovations, and network with other senior executives. The 44th WHC features more than 70 plenary and parallel sessions, 300 speakers, 200 posters, 60 paper presentations, 60 lightning talk presentations and 30 exhibitors.


Dr. Enric Mangas, President of the UCH and Chair of the Organizing Committee, underlined the importance of knowledge exchange between hospital leaders as they focus their efforts on building back from the pandemic:


“In Barcelona we have an outstanding opportunity to move forward together in improving healthcare. And we’ll do so with a firm commitment to people. We propose a journey through all the opportunities offered by technology and knowledge, with an incursion in humanism, to ensure there is health and social care of value for everyone and anyone who needs it. And put in place learnings on how we can transform our healthcare services to be agile, responsive and resilient to meet people’s needs.”


“The World Hospital Congress gives us the chance to reflect on our accomplishments and progress, learn from one another and better navigate what lies ahead,” added Deborah Bowen, FACHE, CAE, president and Chief Executive Officer of the American College of Healthcare Executives Federation who will commence her role as President of the IHF at the closing ceremony.


Related Links:
The International Hospital Federation 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

21 Jan 2022
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
The global immunofluorescence assay (IFA) market is expected to reach USD 4.01 billion by 2028, driven by the increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector.
Read More
21 Jan 2022
Global Digital X-Ray Systems Market to Be Driven by AI-Based Systems and Robotic Devices
The global digital X-ray systems market was valued at USD 11.74 billion in 2020 and is expected to grow at a CAGR of 7.45% during the forecast period 2021 to 2026, due to the rising number of cancer patients and increasing cases of orthopedic diseases/tumors, cardiovascular diseases (CVD), pneumonia, and dental disorders, among others.
Read More
20 Jan 2022
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Illumina Inc. (San Diego, CA, USA) has entered into a partnership with Boehringer Ingelheim (Ingelheim am Rhein, Germany; www.boehringer-ingelheim.com) to develop companion diagnostics (CDx) for several programs in the latter’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Read More
20 Jan 2022
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Oncocyte Corporation (Irvine, CA, USA) has entered into a development and co-marketing agreement for two distributed in vitro diagnostic (IVD) assays on Thermo Fisher Scientific’s (Waltham, MA, USA) Ion Torrent Genexus System. The agreement also grants Oncocyte rights to develop future companion diagnostics on the Genexus System.
Read More
18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
13 Jan 2022
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions